BIOSPYDER TECHNOLOGIES, INC.
- CARLSBAD, CA 92008-8826
- biospyder.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $0
- Awards on record
- 0
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
BIOSPYDER TECHNOLOGIES, INC. has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About BIOSPYDER TECHNOLOGIES, INC.
- Headquarters
- CARLSBAD, CA 92008-8826
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIKLCPP1J49GC5
- CAGE6THH7
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
No federal prime awards on record
Contract vehicles
No contract vehicles on file
Proven teaming graph
Primes it has worked under
- BATTELLE MEMORIAL INSTITUTE
UEI F125YU6SWK59
$839.6K
Subcontractor to this prime · 4 sub-awards · latest May 6, 2026
- National Institutes of Health
- “RAT AND HUMAN SURROGATE S1500+ TEMPO-SEQ KIT (384 SAMPLES)”
- “HUMAN SURROGATE S1500+ TEMPO-SEQ KIT AND PROJECT ACCESS”
- “HUMAN SURROGATE S1500+ TEMPO-SEQ KIT”
- BATTELLE MEMORIAL INSTITUTE
UEI ZFX8JGFQ89F4
$153.1K
Subcontractor to this prime · 1 sub-award · latest Sep 3, 2025
- National Institutes of Health
- “HUMAN SURROGATE S1500+ TEMPO-SEQ”
Subcontractors it has used
No reported sub-awards as a prime contractor.
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · as of Nov 9, 2026 · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 25 awards
- Total awarded
- $19,301,104
- By phase
- SBIR Phase I: 15
- SBIR Phase II: 9
- STTR Phase I: 1
- By agency
- Department of Health and Human Services: 24
- Department of Agriculture: 1
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2023: 2
- 2021: 2
- 2020: 3
- 2019: 2
- 2018: 1
- 2017: 4
- 2016: 3
- 2015: 2
- 2014: 4
- 2013: 2
Awards (most recent first)
Whole blood filter paper assay for Alzheimers Disease
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2023 · $2,638,530
Sep 30, 2023 – Aug 31, 2025
Solicitation PAS22-196 (2022) · Topic NIA
TempO-LINC high throughput high sensitivity single cell gene expression profiling assay Ph II
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2023 · $2,499,921
Jun 22, 2023 – May 31, 2025
Solicitation PA22-176 (2022) · Topic 400
TempO-LINC high throughput, high sensitivity single cell gene expression profiling assay
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $402,266
Apr 15, 2021 – Mar 31, 2022
Solicitation PA19-272 (2019) · Topic 400
TempO-Seq assay and cell panel for assessing impact of genetic diversity on compound bioactivity and toxicity risk
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $252,121
Jan 1, 2021 – Jul 31, 2022
Solicitation ES20-008 (2020) · Topic NIEHS
Functional Read-Out Enabling High Compound Throughput Toxicokinetic Assays
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $224,980
Aug 11, 2020 – Jan 31, 2021
Solicitation PA19-272 (2019) · Topic NIEHS
TempO-Vseq Screen for Genomic Risk of CAD Using Blood from a Finger Prick
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $409,096
Aug 1, 2020 – Jul 31, 2021
Solicitation PA19-272 (2019) · Topic NHLBI
TempO-Seq Profiling of RNA Epitranscriptomic Modifications
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2020 · $1,119,584
Jul 20, 2020 – Jun 30, 2022
Solicitation PAR16-016 (2016) · Topic 172
High-Throughput Assay for Profiling Alternative Splicing and Splicing Regulators
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $349,024
Sep 6, 2019 – Feb 28, 2021
Solicitation PA18-576 (2018) · Topic 172 · Research partner: UNIVERSITY OF PENNSYLVANIA
Whole Blood Filter Paper Assay for Alzheimers Disease
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $436,986
Aug 1, 2019 – Jan 31, 2021
Solicitation PAS18-187 (2018) · Topic NIA
TempO-Seq Profiling of RNA Epitranscriptomic Modifications
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $293,532
Sep 17, 2018 – Feb 29, 2020
Solicitation PAR16-016 (2016) · Topic 172
TempO-Seq Gene Expression Profiling of Intracellular Stained FACS Sorted Cells
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2017 · $2,317,803
Sep 15, 2017 – Aug 31, 2019
Solicitation PA16-287 (2016) · Topic 172
TempO-STAT Citrus Greening Infection Test
SBIR Phase I · Department of Agriculture · 2017 · $99,992
Aug 1, 2017 – Mar 31, 2019
Solicitation year 2017 · Topic 8.2
TempO-Seq for Preserved Tissues in Toxicity Testing Phase II
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2017 · $1,485,159
Jul 1, 2017 – Jun 30, 2019
Solicitation PA15-269 (2015) · Topic NIEHS
TempO-Seq: A Multiplexed Gene Expression Profiling Platform
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2017 · $1,834,744
May 1, 2017 – Feb 28, 2019
Solicitation PA15-269 (2015) · Topic 172
Multiplexed mRNA and miRNA Profiling of Single Cells Phase II
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2016 · $997,861
Sep 22, 2016 – Jun 30, 2018
Solicitation PA13-140 (2013) · Topic 172
TempO-Seq Gene Expression Profiling of Intracellular Stained FACS Sorted Cells
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $224,517
Feb 1, 2016 – Jan 31, 2017
Solicitation PA13-140 (2016) · Topic 172
IGF OT IGF SBIR PHASE I TOPIC CFNA TEMPO SEQ ASSAY
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $270,284
Solicitation year 2016 · Topic NCI
In Situ RNA-FISH with Localized Profiling by Sequencing from FFPE
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $213,490
Apr 1, 2015 – Sep 30, 2016
Solicitation PAR13-327 (2016) · Topic 102
IGF OT IGF "RASL SEQ HTS TOX PROFILER ASSAY"
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2015 · $168,924
Solicitation year 2015 · Topic NIDA
RASL-Seq CTC Assay
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $700,000
Sep 10, 2014 – Jul 31, 2016
Solicitation PA11-335 (2015) · Topic 172
RASL-Seq for Preserved Tissues in Toxicity Testing
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $149,871
Solicitation ES13-009 (2014) · Topic NIEHS · Research partner: Stub
Multiplexed mRNA and miRNA Profiling of Single Cells
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $174,496
Solicitation PA13-140 (2014) · Topic NHGRI · Research partner: Stub
IGF::OT::IGF
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2014 · $1,248,788
Solicitation year 2014 · Topic NIDA · Research partner: Stub
Cell Lysates to Sequencing Reads: A Multiplex Gene Expression Profiling Tool for
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $639,477
Sep 23, 2013 – Jan 31, 2016
Solicitation PA11-335 (2015) · Topic 172
FY 2013 Contract HHSN271201300011C SBIR-I, Topic 004, RASL-Seq HTS Tox Profiler
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $149,658
Solicitation year 2013 · Topic NIDA · Research partner: Stub
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)PrimarySmall business under this code’s size standard
SAM.gov reports this entity as small under 1 of 1 NAICS code. Size is determined per code (SBA size standards).
Product & service codes (PSC)
- AJ11GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
- AJ12GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH
- AN14HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES
- AN22HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; APPLIED RESEARCH
- AN41HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH
- AN42HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
PSC names from the Acquisition.gov PSC Manual (opens in a new tab) (April 2025 edition), checked Nov 12, 2026.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with BIOSPYDER TECHNOLOGIES, INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.